Controlled cooling lowers the graft’s cellular metabolic demand during the interval outside the body. This helps reduce consumption of oxygen and nutrients when normal circulation is absent, limiting conditions that can promote cellular injury. Cooling therefore works as a protective control rather than a replacement for perfusion, supporting tissue viability until transplantation can occur.
Preservation solutions provide a protective chemical environment while the lungs are not connected to the recipient’s circulation. In combination with limited oxygen and nutrient delivery, they help restrain metabolic activity and cellular stress. The effectiveness of this strategy depends on coordinating solution-based protection with temperature control, rather than relying on any single preservation measure.
Edema and ischemic injury are important preservation targets because deterioration during the interval without normal blood flow can compromise graft function. Lung graft preservation addresses these risks by reducing metabolism and maintaining selected supportive conditions. Limiting such injury is clinically relevant because it may lessen the severity of ischemia-reperfusion complications after the graft is implanted.
A preservation workflow begins with donor lung retrieval, followed by controlled cooling and use of a protective preservation solution. The graft then remains under limited oxygen and nutrient support until transplantation, unless ex vivo lung perfusion is added for assessment or rehabilitation. This sequence aims to maintain viability while the organ is transported and prepared for implantation.
Ex vivo lung perfusion circulates a physiologic perfusate through the pulmonary vasculature while the organ remains outside the body. Under monitored conditions, this platform can help assess marginal lungs and may support their rehabilitation before transplantation. Its value is therefore not only preservation, but also providing information about whether an otherwise questionable graft may be usable.
Researchers may apply these strategies when donor lungs require protection between retrieval and transplantation or when an organ’s suitability needs closer evaluation. Ex vivo perfusion is especially relevant to marginal organs, whereas cooling and solution-based methods provide the underlying preservation framework. Together, they can expand the usable donor pool, improve graft assessment, and potentially reduce post-transplant ischemia-reperfusion complications.